Related references
Note: Only part of the references are listed.HDL-Bound Sphingosine 1-Phosphate (S1P) Predicts the Severity of Coronary Artery Atherosclerosis
Katherine Sattler et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
High-Density Lipoprotein Vascular Protective Effects, Dysfunction, and Potential as Therapeutic Target
Thomas F. Luescher et al.
CIRCULATION RESEARCH (2014)
Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate
Iryna Sutter et al.
JOURNAL OF LIPID RESEARCH (2014)
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction
Fabrizio Montecucco et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity
Miguel A. Frias et al.
ATHEROSCLEROSIS (2013)
Interplay Between SAFE and RISK Pathways in Sphingosine-1-Phosphate-Induced Cardioprotection
Sarin J. Somers et al.
CARDIOVASCULAR DRUGS AND THERAPY (2012)
Reconstituted HDL in Acute Coronary Syndromes
Remy Chenevard et al.
CARDIOVASCULAR THERAPEUTICS (2012)
High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate
Rong Tao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease
Katherine J. E. Sattler et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis
Miguel A. Frias et al.
CARDIOVASCULAR RESEARCH (2010)
Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice
Vincent Braunersreuther et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats
Yoshihiro Kiya et al.
ATHEROSCLEROSIS (2009)
High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus
Brian G. Drew et al.
CIRCULATION (2009)
Reconstituted High-Density Lipoprotein Increases Plasma High-Density Lipoprotein Anti-Inflammatory Properties and Cholesterol Efflux Capacity in Patients With Type 2 Diabetes
Sanjay Patel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Apolipoprotein A-IMilano/ROPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart
Marta Marchesi et al.
ATHEROSCLEROSIS (2008)
The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis
Miguel A. Frias et al.
CARDIOVASCULAR RESEARCH (2008)
Infusion of Reconstituted High-Density Lipoprotein Leads to Acute Changes in Human Atherosclerotic Plaque
James A. Shaw et al.
CIRCULATION RESEARCH (2008)
Reconstituted HDL infusion restores endothelial function in patients with type 2 diabetes mellitus
M. Nieuwdorp et al.
DIABETOLOGIA (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis -: A randomized controlled trial
Jean-Claude Tardif et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor
Gregor Theilmeier et al.
CIRCULATION (2006)
Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury
M Marchesi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury
G Rossoni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-α content and enhancing prostaglandin release
L Calabresi et al.
CIRCULATION RESEARCH (2003)
Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFα gene
RM Smith et al.
CARDIOVASCULAR RESEARCH (2002)
Share Paper
